Advertisement

Current Transplantation Reports

, Volume 4, Issue 4, pp 294–303 | Cite as

Report (2017) of the International Registry on Hand and Composite Tissue Allotransplantation (IRHCTT)

  • Palmina PetruzzoEmail author
  • Claudia Sardu
  • Marco Lanzetta
  • Jean Michel Dubernard
Vascularized Composite Allografts (L Cendales and R Barth, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Vascularized Composite Allografts

Abstract

Purpose of Review

Analysis of all upper extremity (UET) and face allotransplantations (FT) reported to the International Registry on Hand and Composite Tissue Transplantation (IRHCTT) by May 2017.

Recent Findings

The IRHCTT includes 66 cases of UET (18 unilateral and 38 bilateral) and 30 of FT. Acute and chronic rejections were reported in the presence of immunosuppression. Complications similar to those reported in solid organ transplantation occurred. UET patient survival was 96.7% at 1, 5, and 10 years after transplantation; graft survival was 90.4% at 1 year and 86.6% at 5 and 10 years. FT patient survival was 96.6% at 1 year and 96.2% at 5 years; graft survival was 96.6% at 1 and 5 years. The majority of UET and FT recipients were satisfied of their graft.

Summary

UET and FT are complex procedures requiring long-life immunosuppression; their success requires the patients’ careful selection, through evaluation, follow-up and compliance to the immunosuppression.

Keywords

Vascularized composite allotransplantation Upper extremity allotransplantation Face allotransplantation Immunosuppressive treatment Outcomes Patient and graft survival 

Notes

Compliance with Ethical Standards

Conflict of Interest

P.P., C.S., M.L., and J.M.D. declare no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Lanzetta M, Petruzzo P, Margreiter R, et al. The International Registry on Hand and Composite Tissue Transplantation. Transplantation. 2005;79(9):1210–4.CrossRefPubMedGoogle Scholar
  2. 2.
    Petruzzo P, Dubernard JM. The International Registry on Hand and Composite Tissue Allotransplantation. Clin Transpl. 2011;27(4):247–53.Google Scholar
  3. 3.
    Cendales LC, Kanitakis J, Schneeberger S, et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant. 2008;8(7):1396–400.CrossRefPubMedGoogle Scholar
  4. 4.
    Lanzetta M, Petruzzo P. A comprehensive functional score system in hand transplantation. In: Lanzetta M, Dubernard JM, editors. Hand transplantation: Springer-Verlag: Italia Milano; 2007.Google Scholar
  5. 5.
    Gummesson C, Atroshi I, Ekdahl C. The disabilities of the arm, shoulder and hand (DASH) outcome questionnaire: longitudinal construct validity and measuring self-rated health change after surgery. BMC Musculoskelet Disord. 2003;16(4):11.CrossRefGoogle Scholar
  6. 6.
    • Howsare M, Jones CM, Ramirez AM. Immunosuppression maintenance in vascularized composite allotransplantation: what is just right? Curr Opin Organ Transplant. 2017;22(5):463–9. This reviews offers a detailed report of the immunosuppressive maintenance therapy for VCA and an interesting discussion on the determination of the right amount of immunosuppression in VCA Google Scholar
  7. 7.
    • Hammond SP. Infections in composite tissue allograft recipients. Infect Dis Clin N Am. 2013;27(2):379–93. This review summarizes infectious complications in recipients of facial and hand allotransplantation and reports infection prophylaxis practice CrossRefGoogle Scholar
  8. 8.
    •• Broyles JM, Alrakan M, Ensor CR, Khalifian S, Kotton CN, Avery RK, et al. Characterization, prophylaxis, and treatment of infectious complications in craniomaxillofacial and upper extremity allotransplantation: a multicenter perspective. Plast Reconstr Surg. 2014;133(4):543e–51e. In this article, the authors review the infectious risks to patients after VCAs. They underline prophylaxis and treatment of infections in these particular recipients of reconstructive transplantation CrossRefPubMedGoogle Scholar
  9. 9.
    Siemionow M, Ozturk C. Face transplantation: outcomes, concerns, controversies, and future directions. J Craniofac Surg. 2012;23(1):254–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Palmina Petruzzo
    • 1
    • 2
    Email author
  • Claudia Sardu
    • 3
  • Marco Lanzetta
    • 4
  • Jean Michel Dubernard
    • 1
  1. 1.Department of TransplantationHopital Edouard HerriotLyonFrance
  2. 2.Department of SurgeryUniversity of CagliariCagliariItaly
  3. 3.Department of Medical Sciences and Public HealthUniversity of CagliariCagliariItaly
  4. 4.Italian Institute of Hand SurgeryMonzaItaly

Personalised recommendations